AIR-TBC · Nationale Postcode Loterij

An AI cough test that screens for tuberculosis in 30 seconds

AIR-TBC asks whether a short cough recording, analysed on a smartphone, can tell a health worker within seconds whether someone is likely to have tuberculosis. No laboratory, no sputum sample and no specialist equipment are needed for that first step. The project is led by the KNCV Tuberculosis Foundation and is being taken into communities in the Democratic Republic of the Congo, Uganda and Zambia.

30sFrom cough recording to result
100,000People to be screened
3Implementation countries
0Sputum samples needed to screen

The innovation

Screening that starts with a sound

Conventional tuberculosis screening asks a lot of the person being screened and of the health system around them. It usually needs a chest X-ray or a sputum sample, a laboratory to process it, and trained staff to interpret what comes back. Each of those steps is a place where someone drops out of the pathway.

AIR-TBC moves the first step to something almost everyone already carries. A person coughs into a smartphone, the recording is analysed, and within about thirty seconds the health worker has an indication of whether tuberculosis is likely. People flagged by the test go on to confirmatory diagnosis; people who are not can be reassured without a laboratory visit.

The point is not to replace diagnosis. It is to widen the mouth of the funnel, so that far more people are screened and the laboratory capacity that does exist is spent on those most likely to need it.

Tuberculosis laboratory work
A triage test, not a diagnosisAI cough analysis indicates likelihood. Confirmatory testing still follows for anyone the test flags.

Why it matters

The barriers this is designed to remove

Every barrier between a symptom and a diagnosis is time in which tuberculosis continues to spread.

No laboratory for triage

The first screening step needs no laboratory infrastructure, which puts screening within reach of community settings and peripheral facilities.

No sputum collection

Producing a sputum sample is difficult for many people, particularly children. A cough recording asks far less of the person being screened.

Immediate result

An answer in about thirty seconds means the conversation about next steps happens while the person is still present, rather than at a follow-up visit many never make.

Earlier interruption of spread

Finding people sooner, including those with drug-resistant disease, shortens the window in which tuberculosis is transmitted to others.

Where the work happens

Three countries, pilot then scale

AIR-TBC begins with pilot phases and moves into large-scale demonstration, with the aim of embedding the approach in national health systems rather than leaving it as a study artefact.

Democratic Republic of the Congo

One of three implementation countries in the project's screening and health-system strengthening work.

Uganda

Uganda is a high-burden setting with an established tuberculosis research and programme infrastructure, and is one of the three AIR-TBC countries.

Zambia

The third implementation country in the project's pilot and demonstration phases.

MRCU's specific role and sites within AIR-TBC are being confirmed and will be published here.

What the project set out to do

Stated aims

1

Screen at scale

Reach 100,000 people with tuberculosis screening across the three implementation countries.

2

Link to care

Give tens of thousands of people access to the diagnostics and treatment they need once screening flags them.

3

Strengthen systems

Build the capacity of health systems in the three countries rather than running a parallel structure alongside them.

4

Embed and scale

Share results with the World Health Organization and the Global Fund to support global acceptance, and embed the innovation in national health systems.

Funding and partners

The organisations behind AIR-TBC

Dedicated funding supports a project led by KNCV, with learning intended to inform wider adoption.

Funding

Nationale Postcode Loterij

The Dutch Postcode Lottery supports the pilot and demonstration phases of AIR-TBC across the Democratic Republic of the Congo, Uganda and Zambia.

Read the funding announcement
Project leadership

KNCV Tuberculosis Foundation

KNCV leads AIR-TBC, bringing its international experience in tuberculosis control to the project's screening and health-system strengthening work.

Visit KNCV

Work with MRCU

Interested in AI-assisted screening research?

MRCU hosts clinical and implementation research on tuberculosis across a hospital platform, an ISO 15189 laboratory and a population cohort.

Start a conversation